KNOTUS Co.Ltd (278650) - Total Liabilities

Latest as of September 2025: ₩44.24 Billion KRW ≈ $29.98 Million USD

Based on the latest financial reports, KNOTUS Co.Ltd (278650) has total liabilities worth ₩44.24 Billion KRW (≈ $29.98 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 278650 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

KNOTUS Co.Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how KNOTUS Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see KNOTUS Co.Ltd assets under control.

KNOTUS Co.Ltd Competitors by Total Liabilities

The table below lists competitors of KNOTUS Co.Ltd ranked by their total liabilities.

Company Country Total Liabilities
Thailand Prime Property Freehold and Leasehold Real Estate Investment Trust
BK:TPRIME
Thailand ฿2.67 Billion
Hamat Group Ltd
TA:HAMAT
Israel ILA978.95 Million
Kizilbuk Gayrimenkul Yatirim Ortakligi AS
IS:KZBGY
Turkey TL10.62 Billion
PROQR THERAPEUTICS EO-04
F:0PQ
Germany €63.38 Million
GREENLAND RESOURCES INC.
F:M0LY
Germany €548.91K
TEMC Co. Ltd.
KQ:425040
Korea ₩248.01 Billion
NINtec Systems Limited
NSE:NINSYS
India Rs527.45 Million
Sammok S-Form Co.Ltd
KQ:018310
Korea ₩110.77 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down KNOTUS Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 278650 equity financing ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.29 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.41 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.28 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how KNOTUS Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for KNOTUS Co.Ltd (2016–2024)

The table below shows the annual total liabilities of KNOTUS Co.Ltd from 2016 to 2024.

Year Total Liabilities Change
2024-12-31 ₩56.45 Billion
≈ $38.26 Million
-17.15%
2023-12-31 ₩68.14 Billion
≈ $46.18 Million
-33.14%
2022-12-31 ₩101.91 Billion
≈ $69.06 Million
+239.26%
2021-12-31 ₩30.04 Billion
≈ $20.36 Million
+46.02%
2020-12-31 ₩20.57 Billion
≈ $13.94 Million
+4.60%
2019-12-31 ₩19.67 Billion
≈ $13.33 Million
-14.76%
2018-12-31 ₩23.07 Billion
≈ $15.64 Million
+38.33%
2017-12-31 ₩16.68 Billion
≈ $11.30 Million
+49.28%
2016-12-31 ₩11.17 Billion
≈ $7.57 Million
--

About KNOTUS Co.Ltd

KQ:278650 Korea Biotechnology
Market Cap
$142.25 Million
₩209.91 Billion KRW
Market Cap Rank
#17947 Global
#766 in Korea
Share Price
₩2485.00
Change (1 day)
-0.60%
52-Week Range
₩1099.00 - ₩4785.00
All Time High
₩36886.01
About

HLB bioStep Co.,Ltd. provides various test services in South Korea. It offers non clinical CRO services for cancer, bone and brain disease, endocrineand metabolic and eye disease, liver and circulatory system disease, dental and gastrointestinal disease, hair growth, kidney and respiratory disease, painmodel, and skin disease. It also offers representative analysis equipment, veterinary drug deve… Read more